Why Rigel Pharmaceuticals, Inc. Shares Poppedhttp://www.fool.com/investing/general/2014/03/06/why-rigel-pharmaceuticals-inc-shares-popped.aspx Alex Planes
March 6, 2014
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Rigel Pharmaceuticals (NASDAQ: RIGL) are trading about 9% higher this afternoon after topping out at a 15% gain in the morning following the company's publication of research results for R118.
So what: The results for studies with Rigel's R118, an orally bioavailable AMPK (AMP-activated protein kinase) activator, were published in the American Journal of Physiology